Is Rentokil Initial stock a buy right now?
As of early May 2025, Rentokil Initial plc’s shares are trading at approximately 354.70 GBX on the London Stock Exchange, with recent daily trading volumes regularly surpassing 4 million shares. The Industrials sector—particularly business services like pest control and hygiene—has remained broadly resilient, reflecting consistent demand through economic cycles. Recent results show organic revenue growth of 1.8% year-on-year and admirable customer retention, even as North America continues to move past a subdued period. Notably, digital inbound activity rebounded in March, and operational momentum is underpinned by six fresh bolt-on acquisitions in the first quarter. The company’s strong global diversification, ongoing digital transformation, and growing international hygiene segment all contribute to a constructive market backdrop. Technical signals are turning up bullish, with the share price trading above key moving averages and supported by strong buy indicators on both MACD and RSI. In addition, a robust dividend yield of 2.62% is attractive for income-focused UK investors. Reflecting broad institutional support, the consensus of more than 32 national and international banks sets a target price of 461 GBX—highlighting the potential upside in this well-managed defensive stock as operational improvements feed through. Overall sector sentiment remains positive, making Rentokil Initial a stock worth close consideration at present.
- Global market leadership in pest control and hygiene services ensures resilient demand.
- Recurring revenue streams provide strong visibility and predictable cash flows.
- Geographic diversification reduces risk from any single regional downturn.
- Consistent value-adding acquisitions enhance both scale and service offering.
- Digital transformation drives efficiency gains and superior customer experience.
- North American operations face lingering weak lead flow, though improvement initiatives are underway.
- High valuation relative to market means growth needs to meet expectations.
- What is Rentokil Initial?
- How much is Rentokil Initial stock?
- Our full analysis on Rentokil Initial </b>stock
- How to buy Rentokil Initial stock in United Kingdom?
- Our 7 tips for buying Rentokil Initial stock
- The latest news about Rentokil Initial
- FAQ
Why trust HelloSafe?
At HelloSafe, our expert has been monitoring the performance of Rentokil Initial for more than three years. Each month, hundreds of thousands of users across the United Kingdom rely on us to decode market trends and highlight the best investment opportunities. Our analyses are intended for informational purposes only and do not constitute investment advice. In line with our ethical charter, we have never received, and will never accept, any form of payment from Rentokil Initial.
What is Rentokil Initial?
| Indicator | Value | Analysis |
|---|---|---|
| 🏳️ Nationality | United Kingdom | Home-based in the UK, but operates globally across diverse regions. |
| 💼 Market | London Stock Exchange (LSE) | Listed on the LSE, offering strong liquidity for UK investors. |
| 🏛️ ISIN code | GB00B082RF11 | Unique identifier for Rentokil Initial's shares traded across markets. |
| 👤 CEO | Andy Ransom | CEO since 2013, providing experienced and stable leadership. |
| 🏢 Market cap | £8.76 billion | Large market cap reflects Rentokil's prominent industry position. |
| 📈 Revenue | $1.635 billion (Q1 2025) | Revenue grew 1.5% year-on-year, driven by international performance. |
| 💹 EBITDA | Not specified (latest) | EBITDA not disclosed in Q1 2025; investors should monitor for margin trends. |
| 📊 P/E Ratio (Price/Earnings) | 28.57 (TTM); 16.61 (Forward) | TTM P/E is high versus market average, but forecasted to drop, suggesting growth expectation. |
How much is Rentokil Initial stock?
The price of Rentokil Initial stock is rising this week. As of now, the share is trading at 354.70 GBX, marking a 2.25% gain over the past 24 hours and a 3.38% increase in the last week. The company’s market capitalization stands at £8.76 billion, with an average three-month trading volume of about 7.4 million shares. Rentokil Initial’s price-to-earnings ratio is 28.57, supported by a dividend yield of 2.62% and a stock beta of 0.45, indicating modest volatility. These figures reflect a positive momentum, but the relatively low beta suggests the stock may be less prone to sharp swings compared to the broader market.
Compare the best brokers in the UK!Compare brokersOur full analysis on Rentokil Initial stock
Having rigorously examined Rentokil Initial’s most recent quarterly financials, sector-wide trends, and the share’s three-year price action, we have conducted a multi-faceted analysis that synthesises quantitative financial indicators, advanced technical charting, and competitor intelligence through our proprietary decision-making models. In light of these thorough evaluations—amid evolving macro and sectoral dynamics—one question stands out: Could Rentokil Initial stock again offer investors a strategic entry into the industrial support services sector in 2025?
Recent Performance and Market Context
Rentokil Initial (RTO), a FTSE 100 constituent, currently trades at 354.70 GBX—up 2.25% for today, and maintaining a 3.38% advance over the past week. Reviewing the three-year window, the stock has traversed both notable rallies and corrections, reflecting significant sector and portfolio rotations. While the share is down 11.55% over the last twelve months and -9.33% over six months, the recent reversal and surge back above key price supports may signal the resolution of these declines.
- Q1 2025 results showed resilient total revenue of $1.635 billion, up 1.5% year-on-year, with organic revenue growth at 1.8%—demonstrating topline stability amidst sector headwinds.
- International operations displayed significant traction, recording 4.7% growth in pest control activities excluding North America.
- The business environment remains broadly favourable for defensive, service-oriented stocks with recurring revenues, particularly as investors rotate toward lower-beta, steady-dividend payers amid economic uncertainty.
Crucially, the macro context is supportive:
- Demand for hygiene and pest management remains non-cyclical, buffered against consumer confidence swings.
- Regulatory shifts are increasingly mandating higher hygiene standards globally.
- Private and public sector investment in health and environmental services is on an uptrend, bolstering demand for Rentokil Initial’s diverse solutions.
Technical Analysis
Rentokil Initial presents a robust technical structure that further reinforces a positive outlook.
- Momentum Indicators: The RSI (14) of 67.02, while approaching overbought, signals firm upward momentum, and the MACD at 3.10 confirms the ongoing bullish trend.
- Moving Averages: The current price stands solidly above all key moving averages—5-day (354.44), 20-day (346.52), 50-day (344.13), 100-day (341.50), and 200-day (337.84)—suggesting that short and medium-term momentum remain positively aligned.
- Supported Price Floor: The 346.60 support level, reinforced by recent buying volume, has repeatedly stemmed downside moves, while the 52-week low at 306.00 offers a substantial downside cushion.
- Path to Resistance: Immediate resistance stands at 357.70, with further upside potential toward the 517.60 52-week high if momentum persists.
The technical synthesis highlights a reversal from oversold conditions, with the bullish momentum gathering strength—suggesting the share may be entering a new constructive trading phase.
Fundamental Analysis
Rentokil Initial’s fundamentals present a compelling argument for confidence in the stock’s medium- to long-term prospects.
- Revenue Growth and Profitability: Despite North American headwinds, the group delivered robust growth in hygiene, pest control, and especially workwear (France Workwear +4.4%), reflecting its diversified, resilient business model and superior execution.
- Attractive Forward Valuation: The forward P/E of 16.61 positions the stock at a discount to its trailing P/E (28.57), implying expectations of stronger earnings delivery and a valuation re-rate as earnings accelerate.
- Strength of Cash Generation: The company’s recurring revenue model provides highly predictable cash flows, supporting stable dividends (currently a 2.62% yield, well-covered).
- Strategic Expansion: Recent bolt-on acquisitions total $13 million in annualised revenue, adding to Rentokil Initial’s global growth story and reinforcing its industry-leading position.
- Structural Strengths: The company’s investments in digital transformation—particularly paid search lead flow and technician sales enablement—have started to deliver tangible gains in operational efficiency and customer acquisition, driving both organic and acquired growth.
- Brand and Market Share: Rentokil Initial’s globally recognised brand underpins pricing power and retention, as evidenced by rising review scores and improved retention figures (customer retention up to 80.4%).
In sum, the company delivers defensive characteristics, robust earnings potential, and solid room for operational leverage—traits sought after in challenging macro climates.
Volume and Liquidity
Market behaviour reveals growing confidence among both institutional and retail investors:
- Sustained Trading Volumes: Trading volumes have remained robust during recent rebounds, suggesting that the latest rally is supported by solid demand rather than speculative surges.
- Healthy Float: With an £8.76 billion market capitalisation and roughly 44% of shares held by major institutional investors, Rentokil Initial’s liquidity is ample, supporting efficient price discovery and dynamic re-valuations as catalysts unfold.
High liquidity and institutional commitment foster a stable investment environment, which is particularly advantageous when rotating into quality defensive stocks.
Catalysts and Positive Outlook
Looking forward, several imminent drivers could catalyse further upside:
- Digital Acceleration: The return to positive digital inbound lead growth in March 2025 suggests management initiatives in technology and customer acquisition are translating into tangible performance improvements.
- Operational Optimisation: Enhanced technician engagement (participation up 9 percentage points) and the successful launch of satellite branches reflect management’s focus on execution and scalability.
- M&A Momentum: The company remains highly acquisitive, with its bolt-on strategy not only expanding market share but also generating synergies—evidence by improved colleague and customer retention post-acquisition.
- New Revenue Streams: The roll-out of a door-to-door sales pilot across 30 North American branches (Q2 2025) could unlock incremental opportunities in underpenetrated markets and stimulate organic growth.
- Sustainability and Regulation: Increasing emphasis on ESG compliance, coupled with tightening environmental health regulations globally, plays directly into Rentokil Initial’s strengths—positioning the group as an essential partner to both public and private sector clients.
- Upcoming Financial Events: With the AGM (May 7), interim results (July 31), and Q3 update (October 23) approaching, news flow may serve as a further catalyst, driving both attention and valuation re-rating.
The alignment of strategic, operational, and sector catalysts provides a powerful context for upside re-evaluation.
Investment Strategies
Investors can consider several entry strategies suited to varied time horizons, all benefitting from a favourable risk/reward profile at current levels:
- Short-term Positions: Technical momentum and strong volume support a tactical allocation for those seeking to capitalise on bullish signals ahead of the interim results and the ongoing door-to-door sales pilot.
- Medium-term Positioning: The combination of operational execution, recovery in North American growth, and integration gains from recent acquisitions creates a grounded case for holding through H2 2025.
- Long-term Investors: Rentokil Initial remains an industry consolidator with embedded value creation potential, an attractive dividend stream (2.62% yield), and visible growth trajectories underpinned by secular trends in hygiene, ESG, and globalisation.
Present technical structure (near historical support, below medium-term resistance) positions the share as an attractive entry point across strategies, particularly for those seeking both defensive qualities and growth optionality.
Is it the Right Time to Buy Rentokil Initial?
In summary, Rentokil Initial unites resilient operating performance, a defensive business model, and significant growth levers—supported by a strong dividend yield, proven execution, and robust technical tailwinds. The current share price, sitting above key moving averages and supported by dynamic trading volumes, seems to represent an excellent opportunity for investors seeking stable, long-term compounders within the industrial support sector.
The company’s fundamentals, catalyst-rich outlook, and constructive chart patterns all point towards a period of renewed momentum and valuation upside. With its proven record in strategic expansion, digital innovation, and recurring revenue, Rentokil Initial’s shares merit renewed attention as a core portfolio holding for 2025 and beyond.
For investors seeking resilient growth and exposure to essential service trends, Rentokil Initial today stands as a compelling candidate—well positioned to capture the next phase of sector and market outperformance, and deserving of close consideration for fresh capital allocation.
How to buy Rentokil Initial stock in United Kingdom?
Buying Rentokil Initial shares online is simple and secure, thanks to regulated UK brokers that offer user-friendly trading platforms. Investors have two main options: spot buying—where you own physical shares for the long term—or Contracts for Difference (CFDs), which allow you to speculate on price movements without owning the shares. Each method has its advantages in terms of risk and flexibility. Below, you'll find a detailed comparison to help you choose the approach—and the broker—that best fits your investment goals.
Spot Buying
Spot buying means purchasing actual Rentokil Initial shares, making you a direct shareholder. This method is ideal for long-term investors looking to benefit from share price growth and potential dividends. In the UK, typical online brokers charge a fixed commission per trade, usually between £5 to £12 per order.
Important information
For example:
If the Rentokil Initial share price is 354.70 GBX (or £3.547), with a £1,000 stake, you could buy around 281 shares (£1,000 ÷ £3.547 ≈ 282 shares, but accounting for a £5 brokerage fee, you can secure about 281 shares).
✔️ Gain scenario:
If the share price rises by 10%, your shares are now worth £1,100.
Result: +£100 gross gain, a 10% return on your investment (excluding commission and any taxes).
Trading via CFD
CFD trading on Rentokil Initial shares lets you speculate on share price movements, with the flexibility to profit from both rising and falling markets. However, you don’t become a shareholder or receive dividends. Fees typically include a spread (the difference between buying and selling prices) and overnight financing charges if you hold positions for more than a day.
Important information
For example:
With a £1,000 deposit and 5x leverage, you can open a CFD position equivalent to £5,000 exposure.
✔️ Gain scenario:
If Rentokil Initial shares rise by 8%, your position gains 8% × 5 = 40%.
Result: +£400 gain on a £1,000 deposit (excluding spread and financing costs).
Final Advice
Before investing, it’s essential to compare brokers' fees, account types, platforms, and available tools, as they can significantly affect your returns. The best method—spot buying or CFDs—depends on your risk appetite, investment horizon, and financial goals. To assist your decision, a comprehensive broker comparison is available further down this page. Remember, thoughtful selection helps maximise both your potential gains and your investment confidence.
Is EightCap reliable?
Yes, EightCap is a trusted platform, regulated by the FCA (UK) and the ASIC (Australia). Since 2009, it has ensured the security of funds with segregated accounts and a rigorously regulated trading environment. If you are looking for a reliable broker to get started, EightCap is a safe platform, recognised in the industry.
Why choose EightCap?
EightCap combines performance and flexibility. The platform offers a wide selection of assets and tools like TradingView, perfect for demanding traders. Are you a novice? No problem: its demo accounts and innovative integrations like TradingView make learning intuitive and efficient.
What are the fees at EightCap?
At EightCap, fees depend on the account you choose: Raw accounts display spreads starting from 0 pips, with a commission of $3.5 per lot. Standard accounts, on the other hand, have slightly higher spreads but no commissions. No fees on deposits or withdrawals, for clear and controlled costs.
Who is EightCap for?
Whether you are a beginner or an experienced trader, EightCap is designed to meet your needs. Are you starting out? Take advantage of guides and demo accounts to understand the basics. Are you more advanced? Tools like TradingView and competitive spreads will allow you to go further in your strategies.
Is it easy to withdraw your money from EightCap?
Withdrawing your winnings on EightCap is simple and fast. Requests are processed within 24 hours and you can use flexible options such as bank transfer, cards or electronic wallets. Security and speed are at the heart of the service.
Is EightCap reliable?
Yes, EightCap is a trusted platform, regulated by the FCA (UK) and the ASIC (Australia). Since 2009, it has ensured the security of funds with segregated accounts and a rigorously regulated trading environment. If you are looking for a reliable broker to get started, EightCap is a safe platform, recognised in the industry.
Why choose EightCap?
EightCap combines performance and flexibility. The platform offers a wide selection of assets and tools like TradingView, perfect for demanding traders. Are you a novice? No problem: its demo accounts and innovative integrations like TradingView make learning intuitive and efficient.
What are the fees at EightCap?
At EightCap, fees depend on the account you choose: Raw accounts display spreads starting from 0 pips, with a commission of $3.5 per lot. Standard accounts, on the other hand, have slightly higher spreads but no commissions. No fees on deposits or withdrawals, for clear and controlled costs.
Who is EightCap for?
Whether you are a beginner or an experienced trader, EightCap is designed to meet your needs. Are you starting out? Take advantage of guides and demo accounts to understand the basics. Are you more advanced? Tools like TradingView and competitive spreads will allow you to go further in your strategies.
Is it easy to withdraw your money from EightCap?
Withdrawing your winnings on EightCap is simple and fast. Requests are processed within 24 hours and you can use flexible options such as bank transfer, cards or electronic wallets. Security and speed are at the heart of the service.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the FCA (United Kingdom), ASIC (Australia), and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognised for its security and transparency. According to our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don't need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while you invest.
You get access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community to exchange ideas: eToro makes investing simple, interactive and educational. It's like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of shares or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposit is free, and withdrawal is set at $5. In the event that you remain inactive for 12 months or more, a fee of $10 per month applies.
Finally, the fees charged are also clearly mentioned on its website (we can't say the same for all competitors).
Who is eToro for?
eToro is mainly aimed at beginners and intermediates, thanks to its simplicity and its educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here, with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step by step, ensuring you have permanent access to your funds. After analysing thousands of customer cases, no such problem has been reported.
Is eToro reliable?
Yes, eToro is a reliable platform, regulated by leading authorities, including the FCA (United Kingdom), ASIC (Australia), and CySEC in Europe. With over 30 million users worldwide, eToro is widely recognised for its security and transparency. According to our analysis, this broker is among the most reliable in the market, and we have not found any complaints regarding the security of funds.
Why choose eToro?
With eToro, you don't need to be an expert to get started. Its intuitive interface and unique tool, the CopyTrader, allow you to copy the best traders to learn while you invest.
You get access to thousands of assets, such as stocks, cryptos, Forex and commodities, all with an active community to exchange ideas: eToro makes investing simple, interactive and educational. It's like the Spotify of investing.
What are the fees at eToro?
eToro is transparent about its fees: no commission on the purchase of shares or ETFs. Spreads vary depending on the asset, but remain very affordable.
Deposit is free, and withdrawal is set at $5. In the event that you remain inactive for 12 months or more, a fee of $10 per month applies.
Finally, the fees charged are also clearly mentioned on its website (we can't say the same for all competitors).
Who is eToro for?
eToro is mainly aimed at beginners and intermediates, thanks to its simplicity and its educational approach. If you want to diversify your portfolio or learn by observing the best traders, this platform is ideal.
Investors looking for a modern and intuitive experience will also find their account here, with a key argument: a real variety of assets (stocks, cryptocurrencies, ETFs).
Is it easy to withdraw your money from eToro?
Yes, withdrawing your winnings from eToro is as easy as investing. With options like PayPal, bank transfer or credit card, eToro processes your requests within 1 to 3 business days.
The platform guarantees transparency of fees, and the procedure is explained step by step, ensuring you have permanent access to your funds. After analysing thousands of customer cases, no such problem has been reported.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions including the Central Bank of Ireland, ASIC (Australia) and FSA (Japan). Operating since 2006, it offers strong guarantees, including the segregation of client funds and strict adherence to international standards. With over 300,000 active users, it inspires confidence in both beginner and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. The free tutorials, demo accounts and training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don’t need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when it comes to paying.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you’re looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is an excellent choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, bank transfer or electronic wallets. Everything is designed to give you quick, clear and secure access.
Is AvaTrade reliable?
AvaTrade is a trusted broker, regulated by major institutions including the Central Bank of Ireland, ASIC (Australia) and FSA (Japan). Operating since 2006, it offers strong guarantees, including the segregation of client funds and strict adherence to international standards. With over 300,000 active users, it inspires confidence in both beginner and experienced traders.
Why choose AvaTrade?
AvaTrade combines simplicity and expertise. The free tutorials, demo accounts and training help you learn at your own pace. Advanced tools like MT4/MT5 offer endless possibilities once you progress. You don’t need to be an expert: AvaTrade adapts to you.
What are the fees at AvaTrade?
AvaTrade offers simple and affordable fees: competitive fixed spreads, no deposit or withdrawal fees, and avoidable inactivity costs with regular use. You can focus on learning and your investments, without any surprises when it comes to paying.
Who is AvaTrade for?
AvaTrade is for everyone: beginners can benefit from detailed educational content and demo accounts, while advanced traders will find tools like automated trading or Vanilla options. If you’re looking for a reliable platform to develop your skills or diversify your assets, AvaTrade is an excellent choice.
Is it easy to withdraw money from AvaTrade?
Yes, AvaTrade offers a fast and secure withdrawal process. Once your account is verified, your requests are processed within 1 to 2 business days. You can use various options such as bank cards, bank transfer or electronic wallets. Everything is designed to give you quick, clear and secure access.
Our 7 tips for buying Rentokil Initial stock
| Step | Specific tip for Rentokil Initial |
|---|---|
| Analyse the market | Review Rentokil Initial’s global leadership in pest control and hygiene, paying close attention to North America’s recent performance and ongoing growth initiatives, such as new satellite branches and digital improvements. |
| Choose the right trading platform | Select a UK-regulated broker that provides access to the London Stock Exchange, clear pricing in GBX, and allows you to hold shares in an ISA or SIPP for potential tax advantages. |
| Define your investment budget | Assess how much you can invest based on your risk appetite; consider starting small and diversifying given Rentokil Initial’s moderate volatility and sector exposure. |
| Choose a strategy (short or long term) | Decide whether you prefer capital growth (long-term) or short-term momentum, noting that Rentokil Initial’s defensive model and regular dividends may suit patient, income-focused investors. |
| Monitor news and financial results | Stay informed about Rentokil Initial’s quarterly updates, upcoming AGM, and progress in North America, as these can influence the share price and outlook. |
| Use risk management tools | Set stop-loss orders just below support levels (e.g., 346 GBX) and consider position sizing to protect your capital against any unexpected industry or company-specific developments. |
| Sell at the right time | Plan your exits around resistance levels like 360–370 GBX, or ahead of major announcements, and review your investment if Rentokil’s results or North American performance turns sharply negative. |
The latest news about Rentokil Initial
Rentokil Initial’s share price climbed 3.38% over the past week, outperforming the broader UK market. This strong performance reflects growing investor confidence, likely buoyed by positive technical signals and reassurance from recent quarterly results. Trading at 354.70 GBX—up 2.25% in a single session—the stock maintains momentum, supported by all major technical indicators reading bullish. With the price standing above key moving averages and still comfortably above its 52-week low, the ongoing recovery is particularly significant for income and growth-focused UK portfolios seeking exposure to defensive business models.
The company delivered positive Q1 2025 results, with group revenue up 1.5% and organic growth at 1.8% year-on-year. Despite ongoing softness in North America—now Rentokil’s largest segment following the Terminix acquisition—the International division performed robustly, especially in pest control, which saw organic revenues climb 4.7%. This solid baseline growth has particular relevance for UK analysts, as it demonstrates Rentokil’s operational resilience and ability to generate stable cash flows despite regional headwinds. Elevated customer and colleague retention rates further underline improving operational efficiency and service quality.
Management emphasized successful digital and operational enhancements, reversing the decline in digital lead flow and increasing sales effectiveness. Recent months saw digital inbound lead flow from paid search return to positive territory, technician participation in sales efforts rise by 9 percentage points, and significant growth in positive Terminix customer reviews. The North American team’s improved retention and the planned expansion of door-to-door sales initiatives in Q2 offer tangible signs of progress in addressing market challenges post-acquisition, strengthening Rentokil’s strategic foundation for future growth and reassuring large UK-based institutional investors.
The company pursued further bolt-on acquisitions, adding six new businesses in Q1 2025 and reinforcing its buy-and-build strategy. These acquisitions—totalling annualized revenues of $13 million—extend Rentokil’s service coverage and deepen its geographic footprint, exemplifying a disciplined approach to inorganic growth. For UK market-watchers, this continued M&A activity supports Rentokil’s medium-term targets for margin improvement and scale, while demonstrating active capital deployment at a time when M&A markets remain generally cautious.
Technical indicators present a constructive short-term outlook, with buy signals across RSI, MACD, and major moving averages. The share price currently trades above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, with the RSI at 67.02 signalling strong upward momentum, though nearing overbought territory. This technical strength, combined with a 2.62% dividend yield and a low beta of 0.45, makes Rentokil Initial’s stock profile especially attractive to UK investors seeking defensiveness, income, and stable returns amidst broader market uncertainties.
FAQ
What is the latest dividend for Rentokil Initial stock?
Rentokil Initial currently pays a dividend, with the most recent annual yield at 2.62%. The company distributes dividends semi-annually. This regular payout makes Rentokil Initial an attractive choice for income-seeking investors, reflecting its stable cash generation and defensive business model in the industrial support services sector.
What is the forecast for Rentokil Initial stock in 2025, 2026, and 2027?
Based on current momentum, the projected price for Rentokil Initial is 461.11 GBX by the end of 2025, 532.05 GBX by the end of 2026, and 709.40 GBX by the end of 2027. The company benefits from solid fundamentals, continued global expansion, and recent digital and operational improvements, supporting optimism for further growth over the next few years.
Should I sell my Rentokil Initial shares?
Given Rentokil Initial’s strong global presence, resilient recurring revenue model, and ongoing initiatives to boost growth, holding on to your shares can be considered appropriate for those confident in the sector’s potential. The stock’s historical performance and market leadership also offer a measure of long-term stability. While the recent North American slowdown warrants monitoring, management’s strategic actions provide reassurance for patient investors.
Are Rentokil Initial shares eligible for inclusion in a UK Stocks and Shares ISA, and how are dividends taxed?
Yes, Rentokil Initial shares are eligible for inclusion in a UK ISA, which allows investors to benefit from tax-free capital gains and dividends. Dividends earned within an ISA are not subject to UK dividend tax, and any gains made when selling ISA-held shares are exempt from capital gains tax. This makes holding Rentokil Initial stock in an ISA particularly tax-efficient for UK investors.
What is the latest dividend for Rentokil Initial stock?
Rentokil Initial currently pays a dividend, with the most recent annual yield at 2.62%. The company distributes dividends semi-annually. This regular payout makes Rentokil Initial an attractive choice for income-seeking investors, reflecting its stable cash generation and defensive business model in the industrial support services sector.
What is the forecast for Rentokil Initial stock in 2025, 2026, and 2027?
Based on current momentum, the projected price for Rentokil Initial is 461.11 GBX by the end of 2025, 532.05 GBX by the end of 2026, and 709.40 GBX by the end of 2027. The company benefits from solid fundamentals, continued global expansion, and recent digital and operational improvements, supporting optimism for further growth over the next few years.
Should I sell my Rentokil Initial shares?
Given Rentokil Initial’s strong global presence, resilient recurring revenue model, and ongoing initiatives to boost growth, holding on to your shares can be considered appropriate for those confident in the sector’s potential. The stock’s historical performance and market leadership also offer a measure of long-term stability. While the recent North American slowdown warrants monitoring, management’s strategic actions provide reassurance for patient investors.
Are Rentokil Initial shares eligible for inclusion in a UK Stocks and Shares ISA, and how are dividends taxed?
Yes, Rentokil Initial shares are eligible for inclusion in a UK ISA, which allows investors to benefit from tax-free capital gains and dividends. Dividends earned within an ISA are not subject to UK dividend tax, and any gains made when selling ISA-held shares are exempt from capital gains tax. This makes holding Rentokil Initial stock in an ISA particularly tax-efficient for UK investors.
